| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Economics > Why We Can Learn from Crude Oil Prices History |
|
Answers - Why We Can Learn from Crude Oil Prices History
Just as it is a good idea to learn from the past, we can glean some lessons from looking at cr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ude oil prices history. Here one key example of how understanding the trends involved with thi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in history can help us to be prepared for future situations as oil prices rise and fall periodic lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lly. Many of us lived through the oil crisis of the early 1970's. Few of us were prepared for here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe the sudden leap in oil prices that prompted some major changes in the way we looked at oil con d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro umption and how dependent our society was on that consumption. Because there had never been a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc crisis to match what was happening, more people were driving larger and heavier vehicles. Some easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi people who were just barely getting by had to choose between paying their utilities or getting nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gas for travel back and forth to work. Others had to deal with gas rationing, and would have p and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ riods when they had to find alternate forms of transportation. By being aware of the circumst ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nces that led up to that oil crisis and using crude oil prices history as an indicator, we are ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a in a better position today to prepare for and weather a situation where access to petroleum a dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d other oil products are in short supply to the consumer. Even if the reason is not an embargo cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin noticing the rising cost and dwindling availabiltiy will help us to plan to stock up on non-p tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rishables, use public transportation and maybe even shop closer to home so we can use a bike t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel get around. While we are probably doing a better job with recycling oil products than we hav ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e ever done, reality is that most of us still depend heavily on the production of fresh petrol y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products um and other oils. Crude oil prices history has taught us that having a backup plan in case th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de re is a temporary increase in price, which certainly comes hand in hand with less available pr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip duct, is absolutely necessary if we are to continue to function effectively in our daily lives tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:AdWords Analyzer Review - Pros and Cons 188 Stage Hero's Journey - Monomyth - Period of Obscurity
|